ATE547526T1 - Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen - Google Patents

Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen

Info

Publication number
ATE547526T1
ATE547526T1 AT05743390T AT05743390T ATE547526T1 AT E547526 T1 ATE547526 T1 AT E547526T1 AT 05743390 T AT05743390 T AT 05743390T AT 05743390 T AT05743390 T AT 05743390T AT E547526 T1 ATE547526 T1 AT E547526T1
Authority
AT
Austria
Prior art keywords
leucocytozoonosis
transgenic plants
vaccines based
oral anti
chickens
Prior art date
Application number
AT05743390T
Other languages
English (en)
Inventor
Akira Ito
Toru Gotanda
Shigeki Kobayashi
Katsumi Kume
Takeshi Matsumura
Original Assignee
Kitasato Inst Formerly Known As School Juridical Person Kitasato Gakuen
Nat Inst Of Advanced Ind Scien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst Formerly Known As School Juridical Person Kitasato Gakuen, Nat Inst Of Advanced Ind Scien filed Critical Kitasato Inst Formerly Known As School Juridical Person Kitasato Gakuen
Application granted granted Critical
Publication of ATE547526T1 publication Critical patent/ATE547526T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT05743390T 2004-05-31 2005-05-30 Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen ATE547526T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004160666 2004-05-31
PCT/JP2005/009851 WO2005116216A1 (ja) 2004-05-31 2005-05-30 遺伝子組換え植物による抗原虫病経口ワクチン

Publications (1)

Publication Number Publication Date
ATE547526T1 true ATE547526T1 (de) 2012-03-15

Family

ID=35450895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05743390T ATE547526T1 (de) 2004-05-31 2005-05-30 Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen

Country Status (8)

Country Link
US (1) US8617575B2 (de)
EP (1) EP1767639B1 (de)
JP (1) JP4898432B2 (de)
AT (1) ATE547526T1 (de)
AU (1) AU2005248233C1 (de)
CA (1) CA2567952C (de)
DK (1) DK1767639T3 (de)
WO (1) WO2005116216A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2329845A4 (de) 2008-08-18 2013-08-14 Kitasato Daiichi Sankyo Vaccine Co Ltd Vogelgrippevirus-antigen und boosterimmunisierungsverfahren für vogelgrippeimpfstoff in kombination mit einem mukosalen adjuvans mit wirksamkeit durch orale verabreichung
WO2010087243A1 (ja) * 2009-01-29 2010-08-05 北海三共株式会社 アディポネクチンを含有する経口用摂食調整剤
US10154974B1 (en) 2015-10-16 2018-12-18 The Regents Of The University Of California Use of abscisic acid for the prevention and treatment of malaria
US11427620B2 (en) 2016-09-05 2022-08-30 Hokusan Co., Ltd. Malaria transmission blocking vaccine
CN110596400B (zh) * 2019-09-02 2023-04-07 佛山市正典生物技术有限公司 基于卡氏住白细胞虫重组r7蛋白的间接elisa检测方法及应用
CN110684097B (zh) * 2019-09-02 2023-11-10 佛山市正典生物技术有限公司 卡氏住白细胞虫重组r7蛋白及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002484A1 (en) * 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
US20020006411A1 (en) * 1991-08-26 2002-01-17 Arntzen Charles Joel Vaccines expressed in plants
GB9403819D0 (en) 1994-02-28 1994-04-20 Univ Leeds Control of parasites
JP3582663B2 (ja) * 1994-04-19 2004-10-27 社団法人日本動物用医薬品協会 鶏ロイコチトゾーン免疫原性蛋白質を発現する遺伝子クローン及び鶏ロイコチトゾーン症に対する遺伝子組換えワクチン
JPH10507916A (ja) * 1994-10-24 1998-08-04 ザ テキサス エーアンドエム ユニバーシティ システム トランスジェニック植物による経口免疫
WO1996040229A1 (en) 1995-06-07 1996-12-19 Thomas Jefferson University Vaccines synthesized by transgenic plants
WO2000037609A2 (en) 1998-12-22 2000-06-29 Boyce Thompson Institute For Plant Research At Cornell Orally immunogenic bacterial enterotoxins expressed in transgenic plants
DE60044858D1 (de) * 1999-10-26 2010-09-30 Stichting Dienst Landbouwkundi Säugetierartige Glykosylierung in Pflanzen
JP4501801B2 (ja) 2005-07-15 2010-07-14 株式会社デンソーウェーブ 光学的情報読取装置

Also Published As

Publication number Publication date
EP1767639A1 (de) 2007-03-28
WO2005116216A1 (ja) 2005-12-08
EP1767639A4 (de) 2008-03-05
US20080003243A1 (en) 2008-01-03
JPWO2005116216A1 (ja) 2008-04-03
DK1767639T3 (da) 2012-06-11
AU2005248233B8 (en) 2010-04-01
AU2005248233C1 (en) 2010-08-19
EP1767639B1 (de) 2012-02-29
CA2567952A1 (en) 2005-12-08
AU2005248233B2 (en) 2010-02-18
US8617575B2 (en) 2013-12-31
JP4898432B2 (ja) 2012-03-14
CA2567952C (en) 2016-02-02
AU2005248233A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
ATE547526T1 (de) Orale anti-leucocytozoonosis-impfstoffe basierend auf transgenen pflanzen
ATE461710T1 (de) Nipah-virus-impfstoffe
DE69637481D1 (de) Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
MX2018010586A (es) Nanovacuna de activacion de "sting" para inmunoterapia.
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
EP4043031A3 (de) Antigenkonstrukte gegen zika-virus
PH12015500956A1 (en) Novel mucosal adjuvants and delivery systems
WO2007098718A8 (es) Antígenos vacunales quiméricos contra el virus de la influenza aviar
EA201391200A1 (ru) Способы и композиции для вакцинации от staphylococcus aureus
HRP20170866T1 (hr) Poboljšano cjepivo za mačji kalicivirus
ATE526034T1 (de) Verbesserte inaktivierte fcv-vakzinen
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
DK1594543T3 (da) Hæmmer af immunogen vedhæftning og fremgangsmåde til fremstilling og anvendelse af deraf
BRPI0407727A (pt) adjuvante de vacina de linfócito humano
EA201401044A1 (ru) Модифицированный вирус болезни марека и вакцины на его основе
WO2010033275A3 (en) Orally administerable vaccine for yersinia pestis
JP2018531265A5 (de)
Bassen My Abortions
قيصر نعمة مظلوم الربيعي Effects of Laser Light on Vaccination with Hepatitis B Vaccine
WO2006006165A3 (en) Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders
WO2009117365A3 (en) Vaccine compositions for inducing immune responses against components of drusen
RU2003101793A (ru) Штамм "52/70-м" вируса инфекционной бурсальной болезни для изготовления инактивированной вакцины и оценки их иммуногенности
Yang et al. Clinical Experimental Vaccine Research
RU2004130267A (ru) Способ вакцинации детей против краснухи на крайнем севере